TheraRadar
← Back
Data updated: Mar 29, 2026

PLIVA

CardiovascularInfectious DiseaseNeurology
Generics

PLIVA is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Neurology.

1983
Since
37
Drugs
-
Trials
594
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-12
Manufacturing (CMC)
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 36%
5 drugs
Infectious Disease 21%
3 drugs
Neurology 14%
2 drugs
Immunology 14%
2 drugs
Dermatology 14%
2 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Cardiovascular, Immunology
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology, Immunology
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology